NCT04024761 2026-01-02
A Phase 1 Trial of CIML NK Cell Infusion for Myeloid Disease Relapse After Hematopoietic Cell Transplantation
Dana-Farber Cancer Institute
Phase 1 Recruiting
Dana-Farber Cancer Institute
Masonic Cancer Center, University of Minnesota